Polymeric nanoparticles for chronic wound therapy: integrating polymer bioactivity, semisolid formulation, and the wound microenvironment
Journal of Pharmaceutical Investigation · 11.11.2026
DOI: 10.1007/s40005-026-00841-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Investigation, online erschienen am 11.11.2026. Verfasst von Monica Sakla und 3 weiteren Autor:innen. Die Arbeit nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität des Saarlandes.
Abstract (Originalsprache)
Background Wound healing is governed by the wound microenvironment, which coordinates the cellular and molecular processes required for tissue repair. In chronic wounds, persistent inflammation, oxidative stress, infection, hypoxia, excessive protease activity, and impaired angiogenesis become closely interconnected, creating pathological conditions that sustain tissue damage and delay regeneration. Although topical semisolid formulations are widely used in wound management, they often exhibit limitations that reduce local bioavailability and efficacy. Incorporating polymeric nanoparticles into semisolid matrices has therefore emerged as a promising strategy for combining the practical advantages of topical formulations with the multifunctional capabilities of nanodelivery systems. Area covered This review examines the biochemical and pathological features of the chronic wound microenvironment and their impact on impaired healing. It then discusses nanoparticle-loaded semisolid platforms, including semisolid formulations, the therapeutic benefits of polymeric nanoparticles, and nanoparticle-forming polymers. Particular emphasis is placed on the bioactivity of polymers, which can actively support wound repair through anti-inflammatory, antimicrobial, hemostatic, regenerative, antioxidant, and stimuli-responsive functions beyond their role as carriers. These properties provide a basis for matching polymer chemistry and nanoparticle functionality to dominant pathological barriers within specific wound microenvironments. Expert opinion Finally, we advance a formulation-system perspective in which polymer chemistry, nanoparticle functionality, semisolid matrix behavior, and wound microenvironmental conditions are treated as interdependent design variables. Polymeric nanoparticles offer therapeutic protection, targeted delivery, controlled release, and bioactivity, while the semisolid matrix regulates applicability, retention, dispersion, and release behavior. This microenvironment-matched and matrix-integrated framework may provide a rational foundation for developing precise, multifunctional, and effective next-generation therapies for chronic wounds.
Förderung
- Universität des Saarlandes
Zitieren
APA
Sakla, M., Aziz, S., Mansour, S., & Lee, S. (2026). Polymeric nanoparticles for chronic wound therapy: integrating polymer bioactivity, semisolid formulation, and the wound microenvironment. Journal of Pharmaceutical Investigation. https://doi.org/10.1007/s40005-026-00841-2
Vancouver
Sakla M, Aziz S, Mansour S, Lee S. Polymeric nanoparticles for chronic wound therapy: integrating polymer bioactivity, semisolid formulation, and the wound microenvironment. Journal of Pharmaceutical Investigation. 2026. doi:10.1007/s40005-026-00841-2
BibTeX
@article{Sakla2026,
author = {Sakla, Monica and Aziz, Shahir and Mansour, Samar and Lee, Sangeun},
title = {Polymeric nanoparticles for chronic wound therapy: integrating polymer bioactivity, semisolid formulation, and the wound microenvironment},
journal = {Journal of Pharmaceutical Investigation},
year = {2026},
doi = {10.1007/s40005-026-00841-2}
}
EUVIMED